Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-25-005760
Filing Date
2025-02-14
Accepted
2025-02-14 16:31:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B5 a424b5-stickerprospectussu.htm 424B5 8290
  Complete submission text file 0001628280-25-005760.txt   9304
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-276052 | Film No.: 25629737
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)